Product Information
JR14a is an analog inhibitor of protein kinases, which has shown promising results in the treatment of cancer. It is derived from indirubin, a natural compound found in Chinese urine that has been used for centuries in traditional medicine. JR14a specifically targets tumor cells and induces apoptosis, or programmed cell death, thereby inhibiting the growth and spread of cancer cells. This anticancer drug works by inhibiting protein kinases involved in cellular signaling pathways that regulate cell growth and division. JR14a has shown potential as a therapeutic agent for various types of cancer, including breast, lung, and colon cancer. Its ability to selectively target cancer cells without affecting healthy cells makes it a promising candidate for the development of new anticancer drugs.
Chemical properties
Technical inquiry about: 3D-LWD44041 JR14a
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
